Devices and methods of a medicament-producing implantable matrix
AssigneeHumacyte Global, Inc.
InventorsMehmet H. KURAL, Kaleb NAEGELI, Hong QIAN, Yuling LI, Laura E. NIKLASON
Life of this patent
Estimating the term…
Loading patent…
AssigneeHumacyte Global, Inc.
InventorsMehmet H. KURAL, Kaleb NAEGELI, Hong QIAN, Yuling LI, Laura E. NIKLASON
Estimating the term…
Described herein are variations of a medicament-producing implantable matrix for the treatment of chronic diseases. For example, an implantable matrix may include a cell-coated a human acellular vessel-based vascular graft. The cells may be engineered to produce medicaments capable of treating a chronic disease. A cell-seeded matrix may be implanted adjacent to a patient's blood vessel such that the medicaments produced by the cells are easily released into the patient's blood stream. Additionally, or alternatively, a cell-seeded matrix may treat chronic disease at an environment local to an implantation site. Also described herein are methods for making and use of such implantable matrices.
A medicament-producing implantable matrix comprising a matrix comprising at least one population of cells.
A medicament-producing implantable matrix, comprising:
A method of forming a medicament-producing implantable matrix, comprising:
An apparatus, comprising:
An apparatus, comprising:
A method for forming a functionalized tubular support graft for a vascular graft, comprising:
Dependencies are inferred from the claim text.